Remove 2016 Remove Clinical Development Remove FDA Approval Remove Protein Production
article thumbnail

Beyond Steel Tanks

Codon

Once approved, patent-protected drugs are the highest-margin physical products on the planet—even with the high price of bioreactors. The real cost is clinical development. In 2012, an Israeli company called Protalix gained approval for their plant-based enzyme product for Gaucher’s disease.